Invirase (State of Florida DOH Central Pharmacy)


Welcome to the PulseAid listing for the Invirase drug offered from State of Florida DOH Central Pharmacy. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: State of Florida DOH Central Pharmacy
NON-PROPRIETARY NAME: saquinavir mesylate
SUBSTANCE NAME: SAQUINAVIR MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Invirase HUMAN PRESCRIPTION DRUG Details:

Item DescriptionInvirase from State of Florida DOH Central Pharmacy
LABELER NAME: State of Florida DOH Central Pharmacy
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53808-0674_e981c067-b7f7-440b-a4d3-1cd79038af4a
PRODUCT NDC: 53808-0674
APPLICATION NUMBER: NDA021785

Other SAQUINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.Invirase
State of Florida DOH Central PharmacyInvirase